Primary plasmacytoma involving mediastinal lymph nodes: A diagnostic mimicry of primary mediastinal lymphoma
| dc.contributor.author | Salem, Karma Z. | |
| dc.contributor.author | Nishihori, Taiga | |
| dc.contributor.author | Kharfan-Dabaja, M. A. | |
| dc.contributor.author | Horna, Pedro | |
| dc.contributor.author | Alsina, Melissa | |
| dc.contributor.department | Internal Medicine | |
| dc.contributor.faculty | Faculty of Medicine (FM) | |
| dc.contributor.institution | American University of Beirut | |
| dc.date.accessioned | 2025-01-24T11:48:48Z | |
| dc.date.available | 2025-01-24T11:48:48Z | |
| dc.date.issued | 2016 | |
| dc.description.abstract | Plasmacytomas could involve any organ, and at times might pose a diagnostic challenge when the site of involvement is unusual, or if the presentation is similar to other diseases. We describe a 48-year-old man presenting with worsening shortness of breath and chest discomfort with radiologic evidence of mediastinal enlargement, mimicking a lymphoma with mediastinal involvement. An excisional biopsy of a mediastinal lymph node showed a plasma-cell infiltrate strongly positive for CD138, with a flow-cytometry analysis showing a population of lambda-restricted neoplastic plasma cells. He failed to respond to 50 Gy involved-field radiotherapy, but achieved a partial response to combination chemotherapy. He underwent high-dose chemotherapy with melphalan (200 mg/m2) followed by lenalidomide maintenance, and is in complete remission 18 months postautografting. This case illustrates a unique and rare presentation of primary lymph-node plasmacytomas involving the mediastinum potentially mistaken as lymphoid malignancy. Clinicians should be aware of the plasma-cell origin of the mediastinal neoplastic process. © 2016 King Faisal Specialist Hospital & Research Centre. | |
| dc.identifier.doi | https://doi.org/10.1016/j.hemonc.2015.06.007 | |
| dc.identifier.eid | 2-s2.0-84961164889 | |
| dc.identifier.pmid | 26169239 | |
| dc.identifier.uri | http://hdl.handle.net/10938/30844 | |
| dc.language.iso | en | |
| dc.publisher | King Faisal Specialist Hospital and Research Centre | |
| dc.relation.ispartof | Hematology/ Oncology and Stem Cell Therapy | |
| dc.source | Scopus | |
| dc.subject | Mediastinal involvement | |
| dc.subject | Primary plasmacytoma | |
| dc.subject | Angiogenesis inhibitors | |
| dc.subject | Antineoplastic agents, alkylating | |
| dc.subject | Humans | |
| dc.subject | Lymph nodes | |
| dc.subject | Male | |
| dc.subject | Mediastinal neoplasms | |
| dc.subject | Mediastinum | |
| dc.subject | Melphalan | |
| dc.subject | Middle aged | |
| dc.subject | Plasma cells | |
| dc.subject | Plasmacytoma | |
| dc.subject | Syndecan-1 | |
| dc.subject | Thalidomide | |
| dc.subject | Bortezomib | |
| dc.subject | Cd16 antigen | |
| dc.subject | Cd38 antigen | |
| dc.subject | Cd56 antigen | |
| dc.subject | Cisplatin | |
| dc.subject | Cotrimoxazole | |
| dc.subject | Cyclophosphamide | |
| dc.subject | Dexamethasone | |
| dc.subject | Doxorubicin | |
| dc.subject | Etoposide | |
| dc.subject | Lenalidomide | |
| dc.subject | Stem cell factor receptor | |
| dc.subject | Syndecan 1 | |
| dc.subject | Alkylating agent | |
| dc.subject | Angiogenesis inhibitor | |
| dc.subject | Adult | |
| dc.subject | Article | |
| dc.subject | Autologous hematopoietic stem cell transplantation | |
| dc.subject | Cancer combination chemotherapy | |
| dc.subject | Cancer radiotherapy | |
| dc.subject | Cancer regression | |
| dc.subject | Case report | |
| dc.subject | Cell infiltration | |
| dc.subject | Clinical feature | |
| dc.subject | Drug megadose | |
| dc.subject | Dyspnea | |
| dc.subject | Flow cytometry | |
| dc.subject | Human | |
| dc.subject | Human tissue | |
| dc.subject | Lymph node biopsy | |
| dc.subject | Lymph node metastasis | |
| dc.subject | Maintenance therapy | |
| dc.subject | Mediastinum lymph node | |
| dc.subject | Mediastinum lymphadenopathy | |
| dc.subject | Methicillin resistant staphylococcus aureus infection | |
| dc.subject | Monoclonal immunoglobulinemia | |
| dc.subject | Multiple cycle treatment | |
| dc.subject | Nuclear magnetic resonance imaging | |
| dc.subject | Positron emission tomography | |
| dc.subject | Primary mediastinal lymphoma | |
| dc.subject | Thorax radiography | |
| dc.subject | Treatment failure | |
| dc.subject | Analogs and derivatives | |
| dc.subject | Drug effects | |
| dc.subject | Lymph node | |
| dc.subject | Pathology | |
| dc.subject | Plasma cell | |
| dc.subject | Radiation response | |
| dc.title | Primary plasmacytoma involving mediastinal lymph nodes: A diagnostic mimicry of primary mediastinal lymphoma | |
| dc.type | Article |
Files
Original bundle
1 - 1 of 1